Source - LSE Regulatory
RNS Number : 6554K
Feedback PLC
22 December 2022
 

Feedback plc

 

Director Dealings 

 

Further to announcement 5307K, made on 22 December 2022 at 07:00, outlining Director Dealings, the Company notes that, due to a clerical error, the shares were described as being "subscribed for" rather than "purchased" and the nominal value was given as "0.50 pence", not "£0.50". These were "Ordinary Shares" and not "New Ordinary Shares". There have been no other amends than clarification of purchasing of existing ordinary shares and amended nominal value.

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the frontline clinical technology company, announces the following Directors' dealings:

 

Rory Shaw, Non Executive Chairman, has purchased 22,270 Ordinary Shares at a price of 89.8 pence per Ordinary Share.

 

Philipp Prince, Non Executive Director, has purchased 4,531 Ordinary Shares at a price of 89.9 pence per Ordinary Share.

 

Annemijn Eschauzier, Non Executive Director, has purchased 5,440 Ordinary Shares at a price of 91.9 pence per Ordinary Share.

 

Details of the Ordinary Shares held by these Directors are detailed in the table below:

 

Director/ PDMR

Position

Existing interest in Ordinary Shares

Ordinary Shares purchased

Total beneficial interest in Ordinary Shares

Total interest in Company's issued share capital

Rory Shaw

Non-Executive Chairman

56,303

22,270

78,573

0.59%

Philipp Prince

Non-Executive Director

20,232

4,531

24,763

0.19%

Annemijn Eschauzier

Non-Executive Director

-

5,440

5,440

0.04%

 

The notification set out below, provides further details of such dealings:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Names

 

Rory Shaw

Philipp Prince

Annemijn Eschauzier

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Chairman

Non-Executive Director

Non-Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Feedback plc

b)

 

LEI

 

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.50 each in Feedback plc



Identification code

GB00BJN59X09



b)

 

Nature of the transaction

 

Purchase of Ordinary Shares 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




89.8p

22,270




89.9p

4,531




91.9p

5,440







d)

 

Aggregated information




- Aggregated volume

n/a



- Price

 



e)

 

Date of the transaction

 

21 December 2022

f)

 

Place of the transaction

XLON

 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Anesh Patel, CFO

+44 (0) 20 3997 7634

IR@fbk.com

 


Panmure Gordon (UK) Limited (NOMAD and Broker)

Emma Earl/Freddy Crossley (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500

 


Walbrook PR Ltd

Tel: 020 7933 8780 or feedbackplc@walbrookpr.com

Nick Rome/Joe Walker

07748 325 236 or 07407 020 470

 

About Feedback

 

Feedback plc helps clinical teams to make better decisions faster for patients. We design products that enhance clinician access to patient data and to their colleagues. Our unique approach centres around individual patient episodes, into which we pull relevant clinical data from hospital systems and around which we build remote clinical teams for collaboration. As a result, we produce a digital infrastructure that makes patient data available to clinicians in multiple settings, in a format that enables them to meaningfully interact with it, providing flexibility to clinicians and free movement of patients between provider settings - clinicians can practice from anywhere and patients can attend any care provider for treatment. 

 

Our products Bleepa and CareLocker work together to deliver unparalleled value to our customers. Bleepa is our application layer and sits on top of CareLocker as our data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. Our vision is one where relevant clinical data is always available to the patient as well as to any care setting that they may attend -  a federated data architecture with the patient as the tenant.  

 

The Company has a number of growth opportunities domestically and internationally across a range of markets including the NHS, the veterinary market and private healthcare providers and its highly scalable Software as a Service ("SaaS")-based revenue model is expected to provide increasing levels of visibility as the Company grows its customer base.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTTBTTMTMTBFT
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Feedback PLC (FDBK)

-5.00p (-4.55%)
delayed 15:57PM